Table 2.
Open in new tab

Main speckle-tracking echocardiographic studies assessing right ventricular strain in athletes.

AuthorYear of publicationSports disciplinenGlobal LSBasal LSMid LSApical LSSoftware
Stefani et al.452007Competitive athletes32NA−25.0 ± 4.1%−23.9 ± 4.9% (mid-apical)−23.9 ± 4.9% (mid-apical)EchoPAC, GE
Oxborough et al.462012Endurance athletes102−27.0 ± 6.0% (range −18 to 41%)NANANAEchoPAC, GE
Teske AJ et al.472009Endurance athletes (group 1)/Olympic endurance athletes (group 2)58/63−28.5 ± 2.9%/−27.6 ± 3.1%−24.5 ± 4.9%/−22.1 ± 5.0%−28.0 ± 3.8%/−27.1 ± 3.9%−31.7 ± 4.5%/−31.0 ± 4.6%EchoPAC, GE
Pagourelias et al.502013Endurance/Strength athletes80/28−23.1 ± 3.7%/−25.1 ± 3.2% (septal + free wall segments)NANANAEchoPAC, GE
Esposito et al.512014Top level rowers40−26.3 ± 3.6% (global) −29.1 ± 4.1 (free wall)NANANAEchoPAC, GE
AuthorYear of publicationSports disciplinenGlobal LSBasal LSMid LSApical LSSoftware
Stefani et al.452007Competitive athletes32NA−25.0 ± 4.1%−23.9 ± 4.9% (mid-apical)−23.9 ± 4.9% (mid-apical)EchoPAC, GE
Oxborough et al.462012Endurance athletes102−27.0 ± 6.0% (range −18 to 41%)NANANAEchoPAC, GE
Teske AJ et al.472009Endurance athletes (group 1)/Olympic endurance athletes (group 2)58/63−28.5 ± 2.9%/−27.6 ± 3.1%−24.5 ± 4.9%/−22.1 ± 5.0%−28.0 ± 3.8%/−27.1 ± 3.9%−31.7 ± 4.5%/−31.0 ± 4.6%EchoPAC, GE
Pagourelias et al.502013Endurance/Strength athletes80/28−23.1 ± 3.7%/−25.1 ± 3.2% (septal + free wall segments)NANANAEchoPAC, GE
Esposito et al.512014Top level rowers40−26.3 ± 3.6% (global) −29.1 ± 4.1 (free wall)NANANAEchoPAC, GE
Table 2.
Open in new tab

Main speckle-tracking echocardiographic studies assessing right ventricular strain in athletes.

AuthorYear of publicationSports disciplinenGlobal LSBasal LSMid LSApical LSSoftware
Stefani et al.452007Competitive athletes32NA−25.0 ± 4.1%−23.9 ± 4.9% (mid-apical)−23.9 ± 4.9% (mid-apical)EchoPAC, GE
Oxborough et al.462012Endurance athletes102−27.0 ± 6.0% (range −18 to 41%)NANANAEchoPAC, GE
Teske AJ et al.472009Endurance athletes (group 1)/Olympic endurance athletes (group 2)58/63−28.5 ± 2.9%/−27.6 ± 3.1%−24.5 ± 4.9%/−22.1 ± 5.0%−28.0 ± 3.8%/−27.1 ± 3.9%−31.7 ± 4.5%/−31.0 ± 4.6%EchoPAC, GE
Pagourelias et al.502013Endurance/Strength athletes80/28−23.1 ± 3.7%/−25.1 ± 3.2% (septal + free wall segments)NANANAEchoPAC, GE
Esposito et al.512014Top level rowers40−26.3 ± 3.6% (global) −29.1 ± 4.1 (free wall)NANANAEchoPAC, GE
AuthorYear of publicationSports disciplinenGlobal LSBasal LSMid LSApical LSSoftware
Stefani et al.452007Competitive athletes32NA−25.0 ± 4.1%−23.9 ± 4.9% (mid-apical)−23.9 ± 4.9% (mid-apical)EchoPAC, GE
Oxborough et al.462012Endurance athletes102−27.0 ± 6.0% (range −18 to 41%)NANANAEchoPAC, GE
Teske AJ et al.472009Endurance athletes (group 1)/Olympic endurance athletes (group 2)58/63−28.5 ± 2.9%/−27.6 ± 3.1%−24.5 ± 4.9%/−22.1 ± 5.0%−28.0 ± 3.8%/−27.1 ± 3.9%−31.7 ± 4.5%/−31.0 ± 4.6%EchoPAC, GE
Pagourelias et al.502013Endurance/Strength athletes80/28−23.1 ± 3.7%/−25.1 ± 3.2% (septal + free wall segments)NANANAEchoPAC, GE
Esposito et al.512014Top level rowers40−26.3 ± 3.6% (global) −29.1 ± 4.1 (free wall)NANANAEchoPAC, GE
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close